WallStreetZenWallStreetZen

NASDAQ: BTAI
Bioxcel Therapeutics Inc Stock Ownership - Who owns Bioxcel Therapeutics?

Insider buying vs selling

Have Bioxcel Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Frank YoccaChief Scientific Officer2024-10-037,175$0.55
$3.95kSell
Matthew T. WileyChief Commercial Officer2024-10-036,272$0.55
$3.45kSell
Vincent OneillExecutive Vice President Chief of Product Development and Medical Officer2024-10-035,556$0.55
$3.06kSell
Richard I. SteinhartChief Financial Officer2024-10-037,175$0.55
$3.95kSell
Javier RodriguezChief Legal Officer Senior Vice President and Corporate Secretary2024-10-036,863$0.55
$3.77kSell
Javier RodriguezChief Legal Officer Senior Vice President and Corporate Secretary2024-09-16345$0.69
$238.05Sell
Vimal MehtaCEO and President2024-09-161,150$0.69
$794.65Sell
Vimal MehtaCEO and President2024-09-16832$0.69
$573.25Sell
Vincent OneillExecutive Vice President Chief of Product Development and Medical Officer2024-09-16138$0.69
$95.36Sell
Richard I. SteinhartChief Financial Officer2024-09-16356$0.69
$245.64Sell

1 of 3

BTAI insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BTAI insiders and whales buy or sell their stock.

BTAI Shareholders

What type of owners hold Bioxcel Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Vimal Mehta60.95%24,832,667$16.89MInsider
Bioxcel Holdings Inc43.12%17,566,750$11.95MInsider
Krishnan Nandabalan41.96%17,094,500$11.62MInsider
Rashmi Agarwal21.00%8,554,945$5.82MInsider
Vipin Agarwal21.00%8,554,945$5.82MInsider
Indu R. Gupta20.99%8,550,396$5.81MInsider
Tarun K. Gupta20.99%8,550,396$5.81MInsider
Suganthi Balasubramanian20.98%8,547,750$5.81MInsider
Diwakar Jain20.98%8,547,300$5.81MInsider
Anita Jain20.98%8,547,300$5.81MInsider

1 of 3

BTAI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BTAI4.55%95.45%Net SellingNet Selling
SABS5.64%94.36%Net Buying
PMN10.92%31.29%Net BuyingNet Buying
INKT2.27%63.58%Net BuyingNet Buying
CVKD4.47%95.53%

Bioxcel Therapeutics Stock Ownership FAQ

Who owns Bioxcel Therapeutics?

Bioxcel Therapeutics (NASDAQ: BTAI) is owned by 23.99% institutional shareholders, 503.70% Bioxcel Therapeutics insiders, and 0.00% retail investors. Vimal Mehta is the largest individual Bioxcel Therapeutics shareholder, owning 24.83M shares representing 60.95% of the company. Vimal Mehta's Bioxcel Therapeutics shares are currently valued at $17.88M.

If you're new to stock investing, here's how to buy Bioxcel Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.